VYCOR MEDICAL INC (VYCO)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, VYCOR MEDICAL INC reported revenue of $1.86M, up 17.2% from the prior year. The company ran a net loss, with a net margin of -3.9% and a gross margin of 83.8%. It held $830.4K in total assets against $4.92M in total liabilities.
Key ratios (FY2025)
83.8%
Gross margin
1.8%
Operating margin
-3.9%
Net margin
+17.2%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.86M | $1.59M | $1.46M | $1.22M | $1.39M | $1.14M | $1.39M | $1.51M | $1.38M | — |
| Cost of Revenue | $302.3K | $166.8K | $144.9K | $140.6K | $134.7K | $132.5K | $134.8K | $169.6K | $227.1K | — |
| Gross Profit | $1.56M | $1.42M | $1.32M | $1.08M | $1.26M | $1.01M | $1.26M | $1.34M | $1.16M | $1.27M |
| Operating Income | $33.9K | -$9.1K | $40.2K | -$306.5K | -$436.0K | -$727.4K | -$601.4K | -$1.32M | -$1.31M | -$1.59M |
| Net Income | -$72.4K | -$107.2K | -$69.7K | -$404.9K | -$435.7K | -$822.5K | -$796.2K | -$1.38M | -$1.48M | -$1.65M |
| EPS (Diluted) | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.03 | — | — | — | — | — |
| Total Assets | $830.4K | $998.1K | $992.3K | $860.2K | $935.4K | $986.5K | $1.09M | $1.04M | $1.45M | $1.49M |
| Total Liabilities | $4.92M | $4.69M | $4.32M | $3.80M | $3.33M | $2.97M | — | — | — | — |
| Shareholders' Equity | -$4.09M | -$3.69M | -$3.33M | -$2.94M | $2.40M | -$1.98M | -$1.35M | -$768.8K | $81.4K | -$26.4K |
| Cash & Equivalents | $87.0K | $105.6K | $57.3K | $37.0K | $90.9K | $46.0K | $60.7K | $86.5K | $206.2K | $56.9K |
| Operating Cash Flow | -$13.5K | $60.1K | $29.4K | -$217.0K | $21.4K | -$248.8K | -$6.0K | -$260.3K | -$527.4K | -$496.9K |
| Capital Expenditures | $5.2K | $5.4K | $9.4K | $2.8K | $38.4K | $62.1K | $52.9K | $63.5K | $183.3K | $57.5K |
| Shares Outstanding | 33.37M | 33.37M | 32.63M | 32.53M | 30.82M | 27.43M | 25.29M | 23.14M | 19.82M | 11.34M |